PDA Releases Report on Passive Thermal Protection Systems
The PDA report discusses qualification and operational handling of passive thermal protection systems.
The Parenteral Drug Association (PDA) has released Technical Report No. 72, Passive Thermal Protection Systems for Global Distribution: Qualification and Operational Guidance (TR 72). The report discusses the qualification and operational handling of passive thermal protection systems (TPS) for temperature-controlled distribution of pharmaceutical and biological products. The report provides guidance regarding the materials used in the manufacture of TPS, as well as their characteristics and capabilities. It also gives guidance on the qualification approach, operational use and reuse, and options for recycling at the end of the systems’ life.
According to PDA, many factors play into the decision to use a passive system versus an active system. TR 72 assists “stakeholders in the supply chain to preserve the quality, safety, and efficacy of pharmaceutical and biological products during distribution,” said PDA in a press release.
Source: PDA
EMA Recommends Imfinzi-Based Perioperative Regimen for Treating Resectable NSCLC
March 10th 2025The committee’s recommendation is based on results from a Phase III trial in which Imfinzi demonstrated a reduced risk of recurrence, progression, or death by 32% compared to neoadjuvant chemotherapy alone.
International Women’s Day 2025: A Promising Future for Gender Diversity in Pharma
March 8th 2025In an interview with BioPharm International®, Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
